AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,105,000 | +327.5% | 468,900 | +223.5% | 0.00% | +200.0% |
| Q3 2021 | $1,662,000 | +22.4% | 144,951 | +93.0% | 0.00% | 0.0% |
| Q2 2021 | $1,358,000 | +7047.4% | 75,109 | +7314.5% | 0.00% | – |
| Q1 2021 | $19,000 | -75.6% | 1,013 | -82.1% | 0.00% | – |
| Q4 2020 | $78,000 | +290.0% | 5,659 | +232.7% | 0.00% | – |
| Q3 2020 | $20,000 | -47.4% | 1,701 | -42.1% | 0.00% | – |
| Q2 2020 | $38,000 | +442.9% | 2,937 | +445.9% | 0.00% | – |
| Q1 2020 | $7,000 | -94.9% | 538 | -90.5% | 0.00% | – |
| Q4 2019 | $137,000 | +47.3% | 5,655 | +16.1% | 0.00% | – |
| Q3 2019 | $93,000 | -21.8% | 4,869 | +21.0% | 0.00% | – |
| Q2 2019 | $119,000 | +271.9% | 4,023 | +497.8% | 0.00% | – |
| Q1 2019 | $32,000 | -15.8% | 673 | -36.5% | 0.00% | – |
| Q4 2018 | $38,000 | -19.1% | 1,060 | +40.2% | 0.00% | – |
| Q3 2018 | $47,000 | -9.6% | 756 | -1.3% | 0.00% | – |
| Q2 2018 | $52,000 | +85.7% | 766 | +49.3% | 0.00% | – |
| Q1 2018 | $28,000 | -9.7% | 513 | 0.0% | 0.00% | – |
| Q4 2017 | $31,000 | +24.0% | 513 | 0.0% | 0.00% | – |
| Q3 2017 | $25,000 | -7.4% | 513 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -20.6% | 513 | -31.4% | 0.00% | – |
| Q1 2017 | $34,000 | +21.4% | 748 | 0.0% | 0.00% | – |
| Q4 2016 | $28,000 | +100.0% | 748 | +104.4% | 0.00% | – |
| Q3 2016 | $14,000 | +16.7% | 366 | -63.3% | 0.00% | – |
| Q1 2016 | $12,000 | -97.5% | 998 | -94.8% | 0.00% | -100.0% |
| Q4 2015 | $471,000 | +11675.0% | 19,359 | +16588.8% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 116 | -42.0% | 0.00% | – |
| Q2 2014 | $5,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |